Status:
UNKNOWN
Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008
Lead Sponsor:
Oslo University Hospital
Conditions:
Thromboembolism
Acute Lymphoblastic Leukemia
Eligibility:
All Genders
1-16 years
Brief Summary
The study will examine the prevalence of venous thromboembolism in children with acute lymphoblastic leukaemia treated in accordance with NOPHO ALL-2008. The investigators will prospectively study cli...
Eligibility Criteria
Inclusion
- Acute lymphoblastic leukaemia,
- Age 1 year to 16 years old,
- Central line,
- Protocol NOPHO ALL 2008.
Exclusion
- Refusal of participation,
- Treated according to protocol other than NOPHO ALL 2008.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00982514
Start Date
September 1 2009
End Date
December 1 2014
Last Update
September 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rikshospitalet, Dep of Pediatrics
Oslo, Oslo County, Norway, 0027